115 related articles for article (PubMed ID: 11328787)
1. Antimicrobial susceptibility of blood culture isolates of viridans streptococci: relationship to a change in empirical antibiotic therapy in febrile neutropenia.
Kennedy HF; Gemmell CG; Bagg J; Gibson BE; Michie JR
J Antimicrob Chemother; 2001 May; 47(5):693-6. PubMed ID: 11328787
[TBL] [Abstract][Full Text] [Related]
2. In vitro activities of eight macrolide antibiotics and RP-59500 (quinupristin-dalfopristin) against viridans group streptococci isolated from blood of neutropenic cancer patients.
Alcaide F; Carratala J; Liñares J; Gudiol F; Martin R
Antimicrob Agents Chemother; 1996 Sep; 40(9):2117-20. PubMed ID: 8878591
[TBL] [Abstract][Full Text] [Related]
3. Antibiotic susceptibility of Gram-negatives isolated from bacteremia in children with cancer. Implications for empirical therapy of febrile neutropenia.
Castagnola E; Caviglia I; Pescetto L; Bagnasco F; Haupt R; Bandettini R
Future Microbiol; 2015; 10(3):357-64. PubMed ID: 25812459
[TBL] [Abstract][Full Text] [Related]
4. In vitro inferiority of ceftazidime compared with other beta-lactams for viridans group Streptococcus bacteremia in pediatric oncology patients: implications for antibiotic choices.
Paulus S; Dobson S; Rassekh S; Blondel-Hill E
J Pediatr Hematol Oncol; 2009 Apr; 31(4):267-9. PubMed ID: 19346878
[TBL] [Abstract][Full Text] [Related]
5. Microbiological spectrum and susceptibility patterns of pathogens causing bacteraemia in paediatric febrile neutropenic oncology patients: comparison between two consecutive time periods with use of different antibiotic treatment protocols.
Greenberg D; Moser A; Yagupsky P; Peled N; Hofman Y; Kapelushnik J; Leibovitz E
Int J Antimicrob Agents; 2005 Jun; 25(6):469-73. PubMed ID: 15890499
[TBL] [Abstract][Full Text] [Related]
6. Increased prevalence of penicillin-resistant viridans group streptococci in Japanese children with upper respiratory infection treated by beta-lactam agents and in those with oncohematologic diseases.
Mogi A; Nishi JI; Yoshinaga M; Harada H; Narahara S; Kawakami K; Maruyama I
Pediatr Infect Dis J; 1997 Dec; 16(12):1140-4. PubMed ID: 9427459
[TBL] [Abstract][Full Text] [Related]
7. Clinical characteristics and outcomes of Pseudomonas aeruginosa bacteremia in febrile neutropenic children and adolescents with the impact of antibiotic resistance: a retrospective study.
Kim HS; Park BK; Kim SK; Han SB; Lee JW; Lee DG; Chung NG; Cho B; Jeong DC; Kang JH
BMC Infect Dis; 2017 Jul; 17(1):500. PubMed ID: 28716109
[TBL] [Abstract][Full Text] [Related]
8. In vitro activities of 22 beta-lactam antibiotics against penicillin-resistant and penicillin-susceptible viridans group streptococci isolated from blood.
Alcaide F; Liñares J; Pallares R; Carratala J; Benitez MA; Gudiol F; Martin R
Antimicrob Agents Chemother; 1995 Oct; 39(10):2243-7. PubMed ID: 8619576
[TBL] [Abstract][Full Text] [Related]
9. Increased incidence of bacteraemia due to viridans streptococci in an unselected population of patients with acute myeloid leukaemia.
Persson L; Vikerfors T; Sjöberg L; Engervall P; Tidefelt U
Scand J Infect Dis; 2000; 32(6):615-21. PubMed ID: 11200370
[TBL] [Abstract][Full Text] [Related]
10. Molecular relationships and antimicrobial susceptibilities of viridans group streptococci isolated from blood of neutropenic cancer patients.
Wisplinghoff H; Reinert RR; Cornely O; Seifert H
J Clin Microbiol; 1999 Jun; 37(6):1876-80. PubMed ID: 10325340
[TBL] [Abstract][Full Text] [Related]
11. Antibiotic susceptibility of streptococci isolated from blood from neutropenic patients.
Piérard D; de Meyer A; Lauwers S
Pathol Biol (Paris); 1994 May; 42(5):471-4. PubMed ID: 7824316
[TBL] [Abstract][Full Text] [Related]
12. Cefepime plus amikacin versus piperacillin-tazobactam plus amikacin for initial antibiotic therapy in haematology patients with febrile neutropenia: results of an open, randomized, multicentre trial.
Sanz MA; López J; Lahuerta JJ; Rovira M; Batlle M; Pérez C; Vázquez L; Julià A; Palau J; Gutiérrez M; Capote FJ; Ramos F; Benlloch L; Larrea L; Jarque I;
J Antimicrob Chemother; 2002 Jul; 50(1):79-88. PubMed ID: 12096010
[TBL] [Abstract][Full Text] [Related]
13. Pediatric fever in neutropenia with bacteremia-Pathogen distribution and in vitro antibiotic susceptibility patterns over time in a retrospective single-center cohort study.
Stergiotis M; Ammann RA; Droz S; Koenig C; Agyeman PKA
PLoS One; 2021; 16(2):e0246654. PubMed ID: 33577566
[TBL] [Abstract][Full Text] [Related]
14. Monotherapy with piperacillin/tazobactam versus combination therapy with ceftazidime plus amikacin as an empiric therapy for fever in neutropenic cancer patients.
Hess U; Böhme C; Rey K; Senn HJ
Support Care Cancer; 1998 Jul; 6(4):402-9. PubMed ID: 9695210
[TBL] [Abstract][Full Text] [Related]
15.
Goodlet KJ; Nicolau DP; Nailor MD
Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28923865
[TBL] [Abstract][Full Text] [Related]
16. Meropenem plus amikacin versus piperacillin-tazobactam plus netilmicin as empiric therapy for high-risk febrile neutropenia in children.
Aksoylar S; Cetingül N; Kantar M; Karapinar D; Kavakli K; Kansoy S
Pediatr Hematol Oncol; 2004 Mar; 21(2):115-23. PubMed ID: 15160510
[TBL] [Abstract][Full Text] [Related]
17. Infections caused by viridans streptococci in patients with neutropenia.
Tunkel AR; Sepkowitz KA
Clin Infect Dis; 2002 Jun; 34(11):1524-9. PubMed ID: 12015700
[TBL] [Abstract][Full Text] [Related]
18. Antimicrobial susceptibility of the pathogens of bacteraemia in the UK and Ireland 2001-2002: the BSAC Bacteraemia Resistance Surveillance Programme.
Reynolds R; Potz N; Colman M; Williams A; Livermore D; MacGowan A;
J Antimicrob Chemother; 2004 Jun; 53(6):1018-32. PubMed ID: 15128723
[TBL] [Abstract][Full Text] [Related]
19. Activities of potential therapeutic and prophylactic antibiotics against blood culture isolates of viridans group streptococci from neutropenic patients receiving ciprofloxacin.
McWhinney PH; Patel S; Whiley RA; Hardie JM; Gillespie SH; Kibbler CC
Antimicrob Agents Chemother; 1993 Nov; 37(11):2493-5. PubMed ID: 8285642
[TBL] [Abstract][Full Text] [Related]
20. Antimicrobial susceptibility of viridans group streptococci in Taiwan with an emphasis on the high rates of resistance to penicillin and macrolides in Streptococcus oralis.
Teng LJ; Hsueh PR; Chen YC; Ho SW; Luh KT
J Antimicrob Chemother; 1998 Jun; 41(6):621-7. PubMed ID: 9687100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
